World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
80
Citations
40575
World Ranking
1132
National Ranking
5

David C. Lye publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where David C. Lye sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 358 publications — 86th percentile

86% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

David C. Lye D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where David C. Lye sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 80 D-Index — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

David C. Lye is affiliated with Tan Tock Seng Hospital in Singapore. Their research primarily focuses on the field of Medicine, with a significant concentration in Infectious Diseases. Other subfields include Neurology, Epidemiology, Modeling and Simulation, and Public Health, Environmental and Occupational Health.

The scientist has contributed extensively to topics related to SARS-CoV-2 and COVID-19 research. Their work covers the following main topics:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Long-Term Effects of COVID-19
  • SARS-CoV-2 detection and testing
  • COVID-19 epidemiological studies
  • Vaccine Coverage and Hesitancy
  • Antibiotic Use and Resistance

Recent significant publications by David C. Lye include:

  • Remdesivir for the Treatment of Covid-19 - Final Report, 2020, New England Journal of Medicine
  • Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore, 2020, JAMA
  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19, 2020, New England Journal of Medicine
  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19, 2020, New England Journal of Medicine
  • Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail, 2020, Science

Frequent collaborators include:

  • Barnaby Edward Young
  • Yee-Sin Leo
  • Laurent Rénia
  • Lisa F. P. Ng
  • Siew-Wai Fong

Their research has been disseminated through several publication venues with multiple contributions in these journals and platforms:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Clinical Infectious Diseases
  • Open Forum Infectious Diseases
  • SSRN Electronic Journal
  • Clinical Microbiology and Infection

Best Publications

  • Remdesivir for the Treatment of Covid-19 - Final Report.

    John H. Beigel;Kay M. Tomashek;Lori E. Dodd;Aneesh K. Mehta

  • Epidemiologic Features and Clinical Course of Patients Infected With SARS-CoV-2 in Singapore.

    Barnaby Edward Young;Sean Wei Xiang Ong;Shirin Kalimuddin;Shirin Kalimuddin;Jenny G. Low;Jenny G. Low

  • Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19.

    Andre C Kalil;Thomas F Patterson;Aneesh K Mehta;Kay M Tomashek

  • Remdesivir for 5 or 10 Days in Patients with Severe Covid-19.

    Jason D. Goldman;David C.B. Lye;David S. Hui;Kristen M. Marks

  • Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail.

    Johanna Hansen;Alina Baum;Kristen E. Pascal;Vincenzo Russo

  • A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2-spike protein-protein interaction.

    Chee Wah Tan;Wan Ni Chia;Xijian Qin;Pei Liu

  • Detection of air and surface contamination by SARS-CoV-2 in hospital rooms of infected patients.

    Po Ying Chia;Po Ying Chia;Kristen Kelli Coleman;Yian Kim Tan;Sean Wei Xiang Ong

  • Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance A Randomized Clinical Trial

    Patrick N. A. Harris;Patrick N. A. Harris;Patrick N. A. Harris;Paul A. Tambyah;David C. Lye;David C. Lye;David C. Lye;Yin Mo

  • Investigation of three clusters of COVID-19 in Singapore: implications for surveillance and response measures.

    Rachael Pung;Calvin J. Chiew;Barnaby E. Young;Sarah Chin

  • Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.

    Anthony T. Tan;Martin Linster;Chee Wah Tan;Nina Le Bert

  • Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey.

    Ann Versporten;Peter Zarb;Isabelle Caniaux;Marie Françoise Gros

  • Autoantibodies neutralizing type I IFNs are present in ~ 4% of uninfected individuals over 70 years old and account for ~ 20% of COVID-19 deaths.

    Paul Bastard;Adrian Gervais;Adrian Gervais;Tom Le Voyer;Tom Le Voyer;Jérémie Rosain;Jérémie Rosain

  • Clinical and virological features of SARS-CoV-2 variants of concern: a retrospective cohort study comparing B.1.1.7 (Alpha), B.1.315 (Beta), and B.1.617.2 (Delta).

    Sean Wei Xiang Ong;Calvin J Chiew;Li Wei Ang;Tze-Minn Mak

  • Two linear epitopes on the SARS-CoV-2 spike protein that elicit neutralising antibodies in COVID-19 patients.

    Chek Meng Poh;Guillaume Carissimo;Bei Wang;Siti Naqiah Amrun

  • Assessing Viral Shedding and Infectivity of Tears in Coronavirus Disease 2019 (COVID-19) Patients.

    Ivan Yu Jun Seah;Danielle E. Anderson;Adrian Eng Zheng Kang;Linfa Wang

  • Effects of a major deletion in the SARS-CoV-2 genome on the severity of infection and the inflammatory response: an observational cohort study.

    Barnaby E Young;Barnaby E Young;Siew-Wai Fong;Siew-Wai Fong;Yi-Hao Chan;Tze-Minn Mak

  • Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study

    Po Ying Chia;Po Ying Chia;Sean Wei Xiang Ong;Calvin J. Chiew;Li Wei Ang

  • Evaluation of the Effectiveness of Surveillance and Containment Measures for the First 100 Patients with COVID-19 in Singapore - January 2-February 29, 2020.

    Yixiang Ng;Zongbin Li;Yi Xian Chua;Wei Liang Chaw

  • Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study.

    Wan Ni Chia;Feng Zhu;Sean Wei Xiang Ong;Barnaby Edward Young;Barnaby Edward Young

  • Highly functional virus-specific cellular immune response in asymptomatic SARS-CoV-2 infection.

    Nina Le Bert;Hannah E. Clapham;Anthony T. Tan;Wan Ni Chia

Frequent Co-Authors

Yee Sin Leo
Yee Sin Leo Nanyang Technological University
Barnaby Young
Barnaby Young National Centre for Infectious Diseases
Vernon J. Lee
Vernon J. Lee Ministry of Health
Lisa F. P. Ng
Lisa F. P. Ng Agency for Science, Technology and Research
Laurent Rénia
Laurent Rénia Nanyang Technological University
Paul A. Tambyah
Paul A. Tambyah National University of Singapore
Raymond T. P. Lin
Raymond T. P. Lin National University of Singapore
Lin-Fa Wang
Lin-Fa Wang Duke NUS Graduate Medical School
Antonio Bertoletti
Antonio Bertoletti Duke NUS Graduate Medical School
Vincent H. Tam
Vincent H. Tam University of Houston

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Microbiology opens doors to various specialized fields and career routes. For those considering public health, exploring easy admission online MPH programs can offer a flexible pathway with manageable entry requirements, making the transition smoother for many students.

Careers like becoming a child life specialist salary reflect promising opportunities for microbiology graduates interested in supporting pediatric patients through medical challenges. This role combines healthcare and emotional support, offering a rewarding alternative to lab-focused positions.

For individuals concerned about previous convictions, there are also options worth exploring. Understanding what is the best degree for a convicted felon highlights accessible fields where a background check might not hinder career prospects, including some healthcare and scientific research paths.

Additionally, the growing field of functional medicine provides another route. Learning about the functional medicine nurse salary can motivate microbiology students interested in combining biology with holistic patient care, creating crossover opportunities in nursing and alternative healthcare.

Best Scientists Citing David C. Lye

Trending Scientists

Recently Published Articles